We are live on ! Find out more
Stifel Financial

Stifel Financial Portfolio holdings

AUM $109B
1-Year Est. Return 21.36%
This Fund
S&P 500
This Quarter Est. Return
-11.51%
1 Year Est. Return
+21.36%
3 Year Est. Return
+66.37%
5 Year Est. Return
+85.41%
10 Year Est. Return
+302.98%
AUM
$30.9B
AUM Growth
-$3.98B
Cap. Flow
+$554M
Cap. Flow %
1.79%
Top 10 Hldgs %
13.58%
Holding
2,932
New
186
Increased
1,089
Reduced
1,274
Closed
275

Sector Composition

Rank Sector Weight
1 Technology 12.57%
2 Healthcare 11.99%
3 Financials 10.41%
4 Industrials 7.84%
5 Consumer Staples 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMSI icon
1976
Merit Medical Systems
MMSI
$5.03B
$459K ﹤0.01%
8,158
+3,129
+62% +$186K
TGNA
1977
DELISTED
TEGNA Inc
TGNA
$458K ﹤0.01%
42,173
+24,442
+138% +$295K
UNB icon
1978
Union Bankshares
UNB
$107M
$458K ﹤0.01%
9,576
RWL icon
1979
Invesco S&P 500 Revenue ETF
RWL
$9.6B
$457K ﹤0.01%
9,822
+5,548
+130% +$281K
BAB icon
1980
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$456K ﹤0.01%
15,283
+833
+6% +$24.1K
CLDR
1981
DELISTED
Cloudera, Inc.
CLDR
$456K ﹤0.01%
41,370
+22,110
+115% +$294K
FXN icon
1982
First Trust Energy AlphaDEX Fund
FXN
$384M
$455K ﹤0.01%
39,132
-54,746
-58% -$802K
EFSC icon
1983
Enterprise Financial Services Corp
EFSC
$2.4B
$454K ﹤0.01%
12,028
-373
-3% -$16.6K
SAM icon
1984
Boston Beer
SAM
$1.9B
$454K ﹤0.01%
+1,868
New +$522K
PSP icon
1985
Invesco Global Listed Private Equity ETF
PSP
$232M
$452K ﹤0.01%
+9,051
New +$495K
MLNT
1986
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$452K ﹤0.01%
114,350
+95
+0.1% +$1.22K
NFX
1987
DELISTED
Newfield Exploration
NFX
$451K ﹤0.01%
30,470
-213,106
-87% -$4.29M
EVR icon
1988
Evercore
EVR
$12.4B
$450K ﹤0.01%
6,210
-5,325
-46% -$437K
MMD
1989
MainStay MacKay DefinedTerm Municipal Opportunities Fund
MMD
$279M
$450K ﹤0.01%
23,234
+6,552
+39% +$127K
TDOC icon
1990
Teladoc Health
TDOC
$1.21B
$450K ﹤0.01%
8,952
-5,349
-37% -$327K
TVRD
1991
Tvardi Therapeutics
TVRD
$19M
$449K ﹤0.01%
956
+348
+57% +$224K
CHY
1992
Calamos Convertible and High Income Fund
CHY
$1B
$448K ﹤0.01%
47,274
-3,712
-7% -$39.5K
AMCIU
1993
DELISTED
AMCI Acquisition Corp Unit
AMCIU
$448K ﹤0.01%
+45,000
New +$449K
USIG icon
1994
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$447K ﹤0.01%
+8,430
New +$444K
TIF
1995
DELISTED
Tiffany & Co.
TIF
$447K ﹤0.01%
5,564
+621
+13% +$63.3K
WIX icon
1996
WIX.com
WIX
$2.25B
$445K ﹤0.01%
4,926
+412
+9% +$38.9K
WTS icon
1997
Watts Water Technologies
WTS
$11.7B
$445K ﹤0.01%
7,068
-2,109
-23% -$151K
JLL icon
1998
Jones Lang LaSalle
JLL
$16.6B
$442K ﹤0.01%
3,487
-101
-3% -$13.7K
USX
1999
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$442K ﹤0.01%
77,474
+52,954
+216% +$445K
ATHN
2000
DELISTED
Athenahealth, Inc.
ATHN
$441K ﹤0.01%
3,343
-8,899
-73% -$1.14M

Similar funds

Stifel Financial's Q4 2018 Portfolio in Review

As of Q4 2018, Stifel Financial held 2,932 positions worth $30.9B, down 11% from $34.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Stifel Financial's Q4 2018 filing shows 186 new, 1,089 increased, 1,274 reduced and 275 closed positions. Its largest new stake was Linde: 470,820 shares worth $73.4M. The largest sale was Praxair Inc, an estimated $81.3M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Stifel Financial's largest Q4 2018 buy was Linde: 470,820 shares worth $73.4M.
  • Stifel Financial added most to iShares 0-1 Year Treasury Bond ETF in Q4 2018, an estimated $112M increase.
  • Stifel Financial's biggest Q4 2018 reduction was Omega Healthcare, cutting an estimated $68.7M.
  • Stifel Financial fully exited Praxair Inc in Q4 2018, selling an estimated $81.3M.
  • Stifel Financial's ten largest holdings make up 14% of its $30.9B portfolio in Q4 2018.
  • Stifel Financial opened 186 new positions and closed 275 in Q4 2018.
  • Stifel Financial's portfolio value fell 11% quarter-over-quarter to $30.9B.

Based on Stifel Financial's 13F filing for Q4 2018, filed 13 Feb 2019.